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Background
Flavonoids are present in numerous plant foods, includ-
ing fruits, vegetables, teas, red wine, cocoa, herbs, and
spices. Epidemiological data, along with evidence from
cell, animal, and limited human intervention trial studies
suggest that flavonoids can improve cardiovascular
health and reduce the risk of other ageing-related dis-
eases [1-6]. However, the absorption and metabolism of
flavonoids, their metabolite profile, and their associated
health benefits are highly heterogeneous [7], with the
aetiological basis of this variability currently unknown.
Our recent stable isotope study, which fed an oral bolus
dose of 500 mg 13C-labeled cyanidin-3-glucoside to
healthy men showed a wide inter-individual variability
in anthocyanin metabolism [7].
Methods
The COB (Chocolate, Orange and Blackberry) study is
examining the influence of genotype, age, gender and
composition of the intestinal microbiota on the absorp-
tion, metabolism and elimination (AME) of flavonoids.
It is an acute feeding study with mixed-flavonoids (con-
taining flavan-3-ols, flavanones and anthocyanins) con-
ducted in 120 men and 120 women (Caucasians, of
European Origin), from two different age groups, 18-30
y and 65-77 y. The parent flavonoids and their metabo-
lites will be measured in plasma and urine for up to 48
hours post-feeding. Participants’ genotypes will be estab-
lished using exome sequencing and targeted genotyping
for Single Nucleotide Popymorphisms (SNPs) in genes
associated with i) pathways involved in flavonoid meta-
bolism (in particular phase 1 and 2 enzymes); ii) genes
that may alter the intestinal microbial composition; and
iii) those modulating gut physiology. The composition
of the gut microflora will be analysed by pyrosequencing
of 16S rRNA and metagenomic technologies.
Results
The COB intervention is currently ongoing and due for
completion in October 2014. 142 tagging SNPs have
been identified in candidate genes involved in flavonoid
absorption, metabolism and elimination including LPHs
(deglycosylation), UGTs (glucuronidation), SULTs (sul-
fation), COMT (methylation) and ABC transporters
(such as MRP2) which will be analysed in our study
population. In order to generate pilot data to help
inform the genotyping approach in the COB study, the
impact of a selection of these SNPs (Table 1) on flavo-
noid metabolism and clinical endpoints is being deter-
mined in a completed one year trial involving 47 post-
menopausal women [1].
Implications
The proposed work will advance current knowledge regard-
ing the genetic and physiological determinants of flavonoid
absorption and metabolism. Such information would allow
greater refinement of current recommended intakes of fla-
vonoid rich foods, such as fruits and vegetables
Trial registration
ClinicalTrials.gov identifier: NCT01922869, ISRCT
N14271372
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Table 1
SNP (Gene) Variant 1 number (%) Variant 2 number (%) Variant 3 number (%)
rs4988235 (LPH) AA 19 (40%) AG 21 (45%) GG 6 (13%)
rs3760091 (SULT) CC 10 (21%) GC 19 (40%) GG 18 (38%)
rs4788068 (SULT) AA 8 (17%) GA 21 (45%) GG 18 (38%)
rs2273697 (MRP2) AA 5 (11%) AG 20 (43%) GG 22 (47%)
rs737865 (COMT) AA 25 (53%) AG 21 (45%) GG 1 (2%)
rs4680 (COMT) AA 13 (28%) AG 23 (49%) GG 11 (23%)
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